The new study, published in the American Diabetes Association medical journal, Diabetes Care, compared Avandia heart risks to those of Actos and other ...
The incidence of heart attack was more than double for Avandia compared to its competitor Actos. The researchers chose Avandia to confirm their methodology ...
Actos and avandia are both small molecules that have been designed to activate PPAR gamma and, as you probably know quite well, they lower blood sugar. ...
Email this story